SlideShare a Scribd company logo
SLIDE PRESENTATION
CYTOLOGY
Sansar Babu Tiwari, MBBS, PGY I
Department of Pathology
TUTH
1st August 2019
1
Single Pap-stained Cervical Smear of 38 years female
(Conventional cytology)
Smear shows superficial, intermediate, and parabasal
cells along with few endocervical cells.
Atypical cells are found arranged singly, in sheets and
in clusters throughout the smear.
These cells are round to oval (parabasal) in shape with
dense, scanty cytoplasm, enlarged hyperchromatic
nuclei, coarse chromatin and irregular nuclear rim
with high N : C ratio and inconspicuous nucleoli.
SLIDE PRESENTATION
2
Background shows sheets of neutrophils and
coccobacilli along with hemorrhage.
Necrosis and mitosis is not seen
SLIDE PRESENTATION
3
Specimen: Cervical smear
Adequacy: Satisfactory for evaluation; endocervical component
present
General Categorization*: Epithelial cell abnormality, squamous
Interpretation: High-grade squamous intra-epithelial lesion (HSIL)
Adjunctive Testing*: Not done in smear
Note*: Suggest colposcopic examination
* Optional to mention in Report.
SLIDE PRESENTATION
4
Olympus, 4x
5
Olympus, 4x
6
Olympus, 20x
7
Olympus, 20x
8
Olympus, 40x
9
Olympus, 40x
10
Columnar lining changes into
squamous in TZ
TZ is a dynamic point, keep on
changing. Move out towards
ectocervix during puberty,
pregnancy and pills. Move
inwards when hormonal
influences are absent like after
menopause.
CERVIX
11
BURDEN OF CERVICAL CANCER
WHO:
Cervical cancer is the second most common cancer in women living
in less developed regions with an estimated 570 000 new cases in
2018 (84% of the new cases worldwide).
In 2018, approximately 311 000 women died from cervical cancer;
more than 85% of these deaths occurring in low- and middle-
income countries.
High risk HPV: 16, 18, 31, 33, 35,39, 45, 51, 52, 56, 58, 59, 68, 69, 82
Low risk HPV: 6, 11, 40, 42, 43, 44, 54, 61, 72, 81
On average, 50% of HPV infections are cleared within 8 months and
90% are cleared within 2 years.
CERVICAL CANCER OVERALL BURDEN
12
CERVICAL NEOPLASIA CLASSIFICATION
13
HPV and cervical cancer
14
• Although HPV has been
firmly established as a
common cause of
cervical cancer, it is not
sufficient to cause
cancer.
• Host immune and co-
carcinogen exposure
influences the fate of
HPV and progression to
cancer.
Gardenella and (pre)neoplasia
15
Incidence of cervical cytology
16
United States Preventive Service Task Force
(USPSTF), 2018 recommends:
• Age to initiate: 21 years
• Age to discontinue: 65 years
• Between 21-29 years: Pap test every 3 years
• After 30 years: One of these methods:
• Pap test every 3 years
• hrHPV testing alone every 5 years
• Co-testing (Pap test and HPV testing) every 5 years
Routine Screening of patients
17
OBTAINING PAP SMEAR
18
CONVENTIONAL VS LBP
19
SUREPATH VS THINPREP
20
SUREPATH VS THINPREP
21
SUREPATH VS THINPREP
22
TYPES OF SQUAMOUS CELLS
23
OTHER CELL TYPES
24
SUPERFICIAL CELL
25
INTERMEDIATE CELL
26
PARABASAL CELL
27
ENDOCERVICAL CELL
28
METAPLASTIC CELL
29
30
31
32
Proliferative Phase
33
Ovulatory Phase (14-16 days)
34
Luteal Phase
LSIL cervical cytologic specimens that contain a few cells that
are suspicious for but not diagnostic of HSIL are reported as
atypical squamous cells, cannot exclude a high-grade
squamous intraepithelial lesion(ASC-H). There was previously
no recommendation regarding how to report these.
Benign-appearing endometrial cells are reported only in
women ≥45 years. This is a change from Bethesda 2001, which
used an age threshold of ≥40 years.
Pages: 191  324
Images: 186  370
Bethesda 2014 vs 2001
35
1. Description of specimen type and test requested –
cervical or vaginal sample, conventional Pap smear,
liquid-based cytology, and/or reflex human
papillomavirus (HPV) test.
2. A description of specimen adequacy
3. A general categorization (optional) – Negative,
epithelial cell abnormality, or other
4. An interpretation/result – Either the specimen is NILM
(although organisms and reactive changes may be
present) or there is an epithelial cell abnormality as
defined, or there is another finding(increased risk like
endometrial cells in women ≥45 years).
Bethesda 2014 Overview of Report
36
5. A description of any ancillary testing or automated
review that was performed (eg. HPV, AutoPap)
6. Educational notes and suggestions by the pathologist
(optional)
Bethesda 2014 Overview of Report
37
38
39
1. Cellularity >5000 (LBP), 8000-12000 (CP)
>2000: Low cellularity but satisfactory: Post-radiation, Post-TH vaginal)
2. Endocervical component
EC/TZ is not necessary for adequate specimen, only squamous
cellularity is needed
Adequate TZ requires at least 10 well preserved EC or squamous
metaplastic cells
No relation with further diagnosis with SIL
3. Obscuring factors (Blood, lubricants)
>75% of sq cells (not the slide area) : unsatisfactory
4. HPV testing on unsatisfactory specimen
HPV test could be falsely negative in unsatisfactory specimen
However, if HPV is positive in these specimen, follow up is still needed
ADEQUACY
40
ASC refers to cytologic changes suggestive of SIL, which
are qualitatively and quantitatively insufficient for
definite interpretation
Three essential features
1. Squamous differentiation
2. Increased ratio of nuclear to cytoplasmic area
3. Minimal nuclear hyperchromasia, chromatin
clumping, irregularity, smudging or multinucleation
ATYPICAL SQUAMOUS CELL
41
• Definition: cytological changes suggestive of LSIL that are
quantitatively and qualitatively insufficient for a definitive diagnosis
• CRITERIA
– Cells resemble superficial and intermediate squamous cells in size
and configuration
– Nuclei are approximately
2 and half to three times the area of the nucleus of a normal intermediate
squamous cell or twice the size of a squamous metaplastic cell nucleus.
– Slighlty increased N:C ratio
– Minimal nuclear hyperchromasia and irregularity of chromatin
distribution or nuclear shape
– Nuclear abnormalities associated with dense orangeophilic
cytoplasm (atypical parakeratosis)
ATYPICAL SQUAMOUS CELL -UNDETERMINED
SIGNIFICANCE (ASC-US)
42
ATYPICAL SQUAMOUS CELL -UNDETERMINED
SIGNIFICANCE (ASC-US)
43
ATYPICAL SQUAMOUS CELL -UNDETERMINED
SIGNIFICANCE (ASC-US)
44
ATYPICAL SQUAMOUS CELL -UNDETERMINED
SIGNIFICANCE (ASC-US)
45
• Definition: cytological changes suggestive of HSIL that are
quantitatively and qualitatively insufficient for a definitive diagnosis
• Patterns:
A. Small cells with high N:C Ratios (Atypical immature Metaplasia)
• Cells usually occur singly or in small fragments of less than 10
cells, occasionally in conventional smears, cells may stream in
mucus.
• Cells are size of metaplastic cells with nuclei that are about 1.5
to 2.5 times larger than normal
• N/C ratio may approximate that of HSIL
ASC-H Vs HSIL: Nuclear abnormalities such as hyperchromasia,
chromatin irregularity and abnormal nuclear shapes with focal
irregularity favor an interpretation of HSIL.
ATYPICAL SQUAMOUS CELL –CANNOT EXCLUDE HSIL
(ASC-H)
46
B. Crowded Sheet Pattern:
• Dense cytoplasm, polygonal cell shape and fragments with
sharp linear edges generally favor squamous over
glandular (endocervical) differentiation.
C. ASC-H Mimics:
• Isolated endocervical cells
• Degenerated endometrial cells
• Macrophages
• IUD: may shed rare cells with high N:C ratio
• Pregnancy and post-partum: atypical appearing
decidualized stromal cells
ATYPICAL SQUAMOUS CELL –CANNOT EXCLUDE HSIL
(ASC-H)
47
ATYPICAL SQUAMOUS CELL –CANNOT EXCLUDE HSIL
(ASC-H)
48
• CRITERIA
– Cells occur singly, in clusters, and in sheets
– Cytological changes are usually confined to
squamous cells with ‘mature’ intermediate or
superficial squamous cell- type cytoplasm
– Overall cell size is large, with fairly abundant
‘mature’ well-defined cytoplasm
– Nuclear enlargement more than 3 times the area of
normal intermediate nuclei results in a low but
slightly increased N:C ratio
Low-grade Squamous Intraepithelial Lesion (LSIL)
49
• CRITERIA
– Nuclei are generally hyperchromatic but may be
normochromatic
– Nuclei show variable size (anisonucleosis)
– Chromatin is uniformly distributed and ranges from
coarsely granular to smudgy or densely opaque
– Contour of nuclear membranes is variable ranging
from smooth to very irregular with notches
– Binucleation and multinucleation are common
– Nucleoli are generally absent or inconspicuous if
present
Low-grade Squamous Intraepithelial Lesion (LSIL)
50
• CRITERIA
– Koilocytosis or perinuclear cavitation consisting of a
broad, sharply delineated clear peri-nuclear zone and a
peripheral rim of densely stained cytoplasm is a
characteristic viral cytopathic feature but is not required
for the interpretation of LSIL
– Cells may show increased keratinization with dense,
eosinophilic cytoplasm with little or no evidence of
koilocytosis
– Cells with koilocytosis or dense orangeophilia must also
show nuclear abnoramalities to be diagnostic of LSIL,
perinuclear halos in the absence of nuclear
abnormalities does not qualify for the interpretation of
LSIL
Low-grade Squamous Intraepithelial Lesion (LSIL)
51
Low-grade Squamous Intraepithelial Lesion (LSIL)
52
• Pseudokoilocytosis
• Herpes Cytopathic
Effects
• Radiation Changes
MIMICS OF LSIL
53
L
S
I
L
54
FOLLOW-UP OF LSIL
55
FOLLOW-UP OF LSIL
56
High-grade Squamous Intraepithelial Lesion (HSIL)
57
• CRITERIA
– Cells occur singly, in sheets, or in syncytial aggregates
– Smaller and show less cytoplasmic maturity than cells of
LSIL
– Syncytial aggregates of dysplastic cells may result in
hyperchromatic crowded groups
– Overall cell size is variable, in general, the cells of HSIL
are smaller than those of LSIL. Higher-grade lesions often
contain quite small basal-type cells
– Degree of nuclear enlargement is more variable than
that seen in LSIL. Even if nucleus size is same as that of
LSIL, cytoplasmic area is decreased leading to marked
increase in N:C ratio.
High-grade Squamous Intraepithelial Lesion (HSIL)
58
• CRITERIA
– Nuclei are generally hyperchromatic but may be
normochromatic or even hypochromatic
– Chromatin may be fine or coarsely granular and is evenly
distributed
– Contour of the nuclear membrane is quite irregular and
frequently demonstrates prominent indentations or
grooves
– Nucleoli are generally absent, but may occasionally be
seen, particularly when HSIL extends into endocervical
gland spaces or in the background of reactive or
reparative changes
– Cytoplasm: variable; immature, lacy or delicate or
densely metaplastic ; mature and densely keratinized as
in keratinizing HSIL.
High-grade Squamous Intraepithelial Lesion (HSIL)
59
High-grade Squamous Intraepithelial Lesion (HSIL)
60
• Syncytial Aggregates/ Hyperchromatic Crowded
Groups:
• SIL with Endocervical Gland Involvement
• Endometrial cells or Squamous Repair
• Keratinizing High Grade Lesion
• HSIL in Atrophy
• LSIL with some features suggestive of concurrent
HSIL
Problematic Pattern in HSIL
61
Note the flattening of cells at the edge of cluster.
SIL with EC gland involvement
62
• Isolated cells
Reserve cells
Parabasal cells
Immature sq. met. cells
• Histiocytes or Lymphocytes
Kidney shaped
Nuclear membrane
notching and irregularity
is absent
• Decidualized Stromal cells
History of pregnancy, more
granular but less dense
cytoplasm, prominent
nucleoli.
Mimics of HSIL
63
H
S
I
L
64
Follow-up of HSIL
65
Follow-up of HSIL
66
• Definition:
–WHO, 2014: SCC is an invasive epithelial
tumor composed of squamous cells of
varying degrees of differentiation
Keratinizing vs Non-keratinizing SCC
The Bethesda system doesnot subdivide
squamous cell carcinoma per se.
Squamous Cell Carcinoma
67
• CRITERIA:
– Presents predominantly as isolated, single cells and
less commonly in cellular aggregates
– Marked variation in cellular size and shape is typical,
with caudate and spindle cells that frequently
contain dense orangeophilic cytoplasm
– Nuclei vary markedly in area, nuclear membranes
may be irregular, and numerous dense opaque nuclei
are often present
– Chromatin pattern, when discernible, is coarsely
granular and irregularly distributed with chromatin
clearing
Squamous Cell Carcinoma KERATINIZING
68
• CRITERIA:
– Macronucleoli may be seen but are less common in
NKSCC
– As keratotic changes (hyper or para) may be present
but are not sufficient for the interpretation of
carcinoma in the absence of nuclear abnormalities
– A tumor diasthesis may be present but is usually less
than that seen in NKSCC
Squamous Cell Carcinoma KERATINIZING
69
Squamous Cell Carcinoma KERATINIZING
70
• CRITERIA:
– Cells occur singly or in syncytial aggregates with
poorly defined cell borders
– Cells may be somewhat smaller than those of many
HSIL, but display most of the features of HSIL
– Nuclei demonstrate markedly irregular distribution
of coarsely clumped chromatin with chromatin
clearing
– Nucleoli may be prominent
– A tumor diasthesis consisting of necrotic debris and
broken-down elements is often present
Squamous Cell Carcinoma NON-KERATINIZING
71
Squamous Cell Carcinoma NON-KERATINIZING
72
1. The Bethesda System of Reporting Cervical
Cytopathology, 3rd edition, 2014
2. The Bethesda System and Beyond, BD
Surepath
3. Robbins and Cotran Pathological Basis of
Disease, 9th edition, 2015
4. Uptodate, 2019
5. www.ncbi.nlm.nih.gov/pubmed
REFERENCES:
73
74

More Related Content

What's hot

Atlas on bethesda system for reporting cervical cytology
Atlas on bethesda system for reporting cervical cytologyAtlas on bethesda system for reporting cervical cytology
Atlas on bethesda system for reporting cervical cytology
Ashish Jawarkar
 
Molecular profiling of breast cancer
Molecular profiling of breast cancerMolecular profiling of breast cancer
Molecular profiling of breast cancer
dhanya89
 
Interpretation of testicular biopsy
Interpretation of testicular biopsyInterpretation of testicular biopsy
Interpretation of testicular biopsy
Appy Akshay Agarwal
 
Endometrial histopathology-Basics
Endometrial histopathology-BasicsEndometrial histopathology-Basics
Endometrial histopathology-Basics
ashish223
 
cytology of the breast
cytology of the breastcytology of the breast
cytology of the breast
Hayelom kassaye
 
Milan cytology reporting
Milan cytology reportingMilan cytology reporting
Milan cytology reporting
Argha Baruah
 
Small round cell tumors
Small round cell tumorsSmall round cell tumors
Small round cell tumors
Dr Niharika Singh
 
approach to lymph node cytology part 1
approach to lymph node cytology part 1approach to lymph node cytology part 1
approach to lymph node cytology part 1
Kamalesh Lenka
 
Immunohistochemistry in diagnosis of soft tissue tumours seminar
Immunohistochemistry in diagnosis of soft tissue tumours seminarImmunohistochemistry in diagnosis of soft tissue tumours seminar
Immunohistochemistry in diagnosis of soft tissue tumours seminar
Pannaga Kumar
 
The bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathology The bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathology
dhanya89
 
Fnac of salivary gland tumour
Fnac of salivary gland tumourFnac of salivary gland tumour
Fnac of salivary gland tumour
aghara mahesh
 
Pancreas cytology
Pancreas cytologyPancreas cytology
Pancreas cytology
Sansar Babu Tiwari
 
Madhuri ppt path
Madhuri ppt pathMadhuri ppt path
Madhuri ppt path
Madhuri Reddy
 
Imprint cytology
Imprint cytology Imprint cytology
Imprint cytology
Sindhuja Yella
 
1. pap smear seminar
1. pap smear seminar1. pap smear seminar
1. pap smear seminar
Dr SANTHIPRIYA GOPASANA
 
Renal pediatric tumors
Renal pediatric tumorsRenal pediatric tumors
Renal pediatric tumors
MIMSR Medical college,Latur
 
IHC in breast pathology
IHC in breast pathologyIHC in breast pathology
IHC in breast pathology
namrathrs87
 
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist
Lifecare Centre
 
Hormonal cytology
Hormonal cytologyHormonal cytology
Hormonal cytology
Ankita072
 

What's hot (20)

Atlas on bethesda system for reporting cervical cytology
Atlas on bethesda system for reporting cervical cytologyAtlas on bethesda system for reporting cervical cytology
Atlas on bethesda system for reporting cervical cytology
 
Molecular profiling of breast cancer
Molecular profiling of breast cancerMolecular profiling of breast cancer
Molecular profiling of breast cancer
 
Interpretation of testicular biopsy
Interpretation of testicular biopsyInterpretation of testicular biopsy
Interpretation of testicular biopsy
 
Endometrial histopathology-Basics
Endometrial histopathology-BasicsEndometrial histopathology-Basics
Endometrial histopathology-Basics
 
cytology of the breast
cytology of the breastcytology of the breast
cytology of the breast
 
Milan cytology reporting
Milan cytology reportingMilan cytology reporting
Milan cytology reporting
 
Small round cell tumors
Small round cell tumorsSmall round cell tumors
Small round cell tumors
 
approach to lymph node cytology part 1
approach to lymph node cytology part 1approach to lymph node cytology part 1
approach to lymph node cytology part 1
 
Immunohistochemistry in diagnosis of soft tissue tumours seminar
Immunohistochemistry in diagnosis of soft tissue tumours seminarImmunohistochemistry in diagnosis of soft tissue tumours seminar
Immunohistochemistry in diagnosis of soft tissue tumours seminar
 
The bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathology The bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathology
 
Fnac of salivary gland tumour
Fnac of salivary gland tumourFnac of salivary gland tumour
Fnac of salivary gland tumour
 
Pancreas cytology
Pancreas cytologyPancreas cytology
Pancreas cytology
 
Madhuri ppt path
Madhuri ppt pathMadhuri ppt path
Madhuri ppt path
 
Imprint cytology
Imprint cytology Imprint cytology
Imprint cytology
 
1. pap smear seminar
1. pap smear seminar1. pap smear seminar
1. pap smear seminar
 
Renal pediatric tumors
Renal pediatric tumorsRenal pediatric tumors
Renal pediatric tumors
 
IHC in breast pathology
IHC in breast pathologyIHC in breast pathology
IHC in breast pathology
 
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist
 
Fnac breast
Fnac breastFnac breast
Fnac breast
 
Hormonal cytology
Hormonal cytologyHormonal cytology
Hormonal cytology
 

Similar to Bethesda Cervical CYtology

Cervix cyto
Cervix cytoCervix cyto
Cervix cyto
Rajesh Deo
 
Abnormal Cervical Smear Presentation .pptx
Abnormal Cervical Smear Presentation .pptxAbnormal Cervical Smear Presentation .pptx
Abnormal Cervical Smear Presentation .pptx
UzomaBende
 
preinvasive lesion of cervix and management ,quick revise tool
preinvasive lesion of cervix and management ,quick revise toolpreinvasive lesion of cervix and management ,quick revise tool
preinvasive lesion of cervix and management ,quick revise tool
mahadevbpatil
 
UPDATES IN THE BETHESDA SYSTEM FOR REPORTING THYROID.pptx
UPDATES IN THE BETHESDA SYSTEM FOR REPORTING THYROID.pptxUPDATES IN THE BETHESDA SYSTEM FOR REPORTING THYROID.pptx
UPDATES IN THE BETHESDA SYSTEM FOR REPORTING THYROID.pptx
jenishJebadurai1
 
The bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathologyThe bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathology
Indira Shastry
 
Chapter 2.4 cancer screening
Chapter 2.4 cancer screeningChapter 2.4 cancer screening
Chapter 2.4 cancer screening
Nilesh Kucha
 
Cervix bethesda system
Cervix bethesda systemCervix bethesda system
Cervix bethesda system
Dr. Sobia Khalid
 
Cervix-bethesda system | Abdul Quddus
Cervix-bethesda system | Abdul QuddusCervix-bethesda system | Abdul Quddus
Cervix-bethesda system | Abdul Quddus
Abdul Quddus
 
Solitary thyroid nodule
Solitary thyroid nodule Solitary thyroid nodule
Solitary thyroid nodule
Jaydeep Malakar
 
Bethesda system for cervix cytology
Bethesda system for cervix cytologyBethesda system for cervix cytology
Bethesda system for cervix cytology
Ravi Kumar Meena
 
ROLE_OF_CERVICAL_CYTOLOGY_IN_SCREENING.pptx
ROLE_OF_CERVICAL_CYTOLOGY_IN_SCREENING.pptxROLE_OF_CERVICAL_CYTOLOGY_IN_SCREENING.pptx
ROLE_OF_CERVICAL_CYTOLOGY_IN_SCREENING.pptx
Nirupama kothari
 
paris presentation.pptx
paris presentation.pptxparis presentation.pptx
paris presentation.pptx
KarishmaBhuyan
 
Testicular tumors.pptx
Testicular tumors.pptxTesticular tumors.pptx
Testicular tumors.pptx
Utkarsh Singhal
 
pap-smear-interpretation.pptx
pap-smear-interpretation.pptxpap-smear-interpretation.pptx
pap-smear-interpretation.pptx
MeshalAlobaid3
 
Cervical precancerous lesions and cervical cancer
Cervical precancerous lesions and cervical cancerCervical precancerous lesions and cervical cancer
Cervical precancerous lesions and cervical cancer
Marmara University School of Medicine
 
Immunohistochemistry in breast lesions
Immunohistochemistry in breast lesionsImmunohistochemistry in breast lesions
Immunohistochemistry in breast lesions
Ashish Jawarkar
 
PAP TEST 2023 ALEXANDRIA FINAL.pdf
PAP TEST  2023 ALEXANDRIA FINAL.pdfPAP TEST  2023 ALEXANDRIA FINAL.pdf
PAP TEST 2023 ALEXANDRIA FINAL.pdf
ZuhriMardiah2
 
Dr._Ameli._case_presentation_urinary_cytology.pptx
Dr._Ameli._case_presentation_urinary_cytology.pptxDr._Ameli._case_presentation_urinary_cytology.pptx
Dr._Ameli._case_presentation_urinary_cytology.pptx
FereshtehAmeli1
 
Diagnostic challenges in endocervical adenocarcinoma
Diagnostic challenges in endocervical adenocarcinomaDiagnostic challenges in endocervical adenocarcinoma
Diagnostic challenges in endocervical adenocarcinoma
PritiToppo2
 

Similar to Bethesda Cervical CYtology (20)

Cervix cyto
Cervix cytoCervix cyto
Cervix cyto
 
Abnormal Cervical Smear Presentation .pptx
Abnormal Cervical Smear Presentation .pptxAbnormal Cervical Smear Presentation .pptx
Abnormal Cervical Smear Presentation .pptx
 
preinvasive lesion of cervix and management ,quick revise tool
preinvasive lesion of cervix and management ,quick revise toolpreinvasive lesion of cervix and management ,quick revise tool
preinvasive lesion of cervix and management ,quick revise tool
 
UPDATES IN THE BETHESDA SYSTEM FOR REPORTING THYROID.pptx
UPDATES IN THE BETHESDA SYSTEM FOR REPORTING THYROID.pptxUPDATES IN THE BETHESDA SYSTEM FOR REPORTING THYROID.pptx
UPDATES IN THE BETHESDA SYSTEM FOR REPORTING THYROID.pptx
 
The bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathologyThe bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathology
 
Cin
CinCin
Cin
 
Chapter 2.4 cancer screening
Chapter 2.4 cancer screeningChapter 2.4 cancer screening
Chapter 2.4 cancer screening
 
Cervix bethesda system
Cervix bethesda systemCervix bethesda system
Cervix bethesda system
 
Cervix-bethesda system | Abdul Quddus
Cervix-bethesda system | Abdul QuddusCervix-bethesda system | Abdul Quddus
Cervix-bethesda system | Abdul Quddus
 
Solitary thyroid nodule
Solitary thyroid nodule Solitary thyroid nodule
Solitary thyroid nodule
 
Bethesda system for cervix cytology
Bethesda system for cervix cytologyBethesda system for cervix cytology
Bethesda system for cervix cytology
 
ROLE_OF_CERVICAL_CYTOLOGY_IN_SCREENING.pptx
ROLE_OF_CERVICAL_CYTOLOGY_IN_SCREENING.pptxROLE_OF_CERVICAL_CYTOLOGY_IN_SCREENING.pptx
ROLE_OF_CERVICAL_CYTOLOGY_IN_SCREENING.pptx
 
paris presentation.pptx
paris presentation.pptxparis presentation.pptx
paris presentation.pptx
 
Testicular tumors.pptx
Testicular tumors.pptxTesticular tumors.pptx
Testicular tumors.pptx
 
pap-smear-interpretation.pptx
pap-smear-interpretation.pptxpap-smear-interpretation.pptx
pap-smear-interpretation.pptx
 
Cervical precancerous lesions and cervical cancer
Cervical precancerous lesions and cervical cancerCervical precancerous lesions and cervical cancer
Cervical precancerous lesions and cervical cancer
 
Immunohistochemistry in breast lesions
Immunohistochemistry in breast lesionsImmunohistochemistry in breast lesions
Immunohistochemistry in breast lesions
 
PAP TEST 2023 ALEXANDRIA FINAL.pdf
PAP TEST  2023 ALEXANDRIA FINAL.pdfPAP TEST  2023 ALEXANDRIA FINAL.pdf
PAP TEST 2023 ALEXANDRIA FINAL.pdf
 
Dr._Ameli._case_presentation_urinary_cytology.pptx
Dr._Ameli._case_presentation_urinary_cytology.pptxDr._Ameli._case_presentation_urinary_cytology.pptx
Dr._Ameli._case_presentation_urinary_cytology.pptx
 
Diagnostic challenges in endocervical adenocarcinoma
Diagnostic challenges in endocervical adenocarcinomaDiagnostic challenges in endocervical adenocarcinoma
Diagnostic challenges in endocervical adenocarcinoma
 

More from Sansar Babu Tiwari

Liver cytology
Liver cytologyLiver cytology
Liver cytology
Sansar Babu Tiwari
 
Kidney transplant
Kidney transplantKidney transplant
Kidney transplant
Sansar Babu Tiwari
 
Olga medicine
Olga medicineOlga medicine
Olga medicine
Sansar Babu Tiwari
 
Acute Leukemia Cytogenetics
Acute Leukemia CytogeneticsAcute Leukemia Cytogenetics
Acute Leukemia Cytogenetics
Sansar Babu Tiwari
 
ALD, Cirrhosis, PBC and PSC
ALD, Cirrhosis, PBC and PSCALD, Cirrhosis, PBC and PSC
ALD, Cirrhosis, PBC and PSC
Sansar Babu Tiwari
 
Chronic lymphocytic leukemia
Chronic lymphocytic leukemiaChronic lymphocytic leukemia
Chronic lymphocytic leukemia
Sansar Babu Tiwari
 
Pulmonary pathology of corona virus
Pulmonary pathology of corona virusPulmonary pathology of corona virus
Pulmonary pathology of corona virus
Sansar Babu Tiwari
 
Pericardial fluid eosinophilia
Pericardial fluid eosinophiliaPericardial fluid eosinophilia
Pericardial fluid eosinophilia
Sansar Babu Tiwari
 
Corona virus
Corona virusCorona virus
Corona virus
Sansar Babu Tiwari
 
Stains
StainsStains
Grossing thyroid gland
Grossing thyroid glandGrossing thyroid gland
Grossing thyroid gland
Sansar Babu Tiwari
 
Journal prostate and crispr
Journal prostate and crisprJournal prostate and crispr
Journal prostate and crispr
Sansar Babu Tiwari
 
Eosinophilia
EosinophiliaEosinophilia
Eosinophilia
Sansar Babu Tiwari
 
Journal article review
Journal article reviewJournal article review
Journal article review
Sansar Babu Tiwari
 

More from Sansar Babu Tiwari (14)

Liver cytology
Liver cytologyLiver cytology
Liver cytology
 
Kidney transplant
Kidney transplantKidney transplant
Kidney transplant
 
Olga medicine
Olga medicineOlga medicine
Olga medicine
 
Acute Leukemia Cytogenetics
Acute Leukemia CytogeneticsAcute Leukemia Cytogenetics
Acute Leukemia Cytogenetics
 
ALD, Cirrhosis, PBC and PSC
ALD, Cirrhosis, PBC and PSCALD, Cirrhosis, PBC and PSC
ALD, Cirrhosis, PBC and PSC
 
Chronic lymphocytic leukemia
Chronic lymphocytic leukemiaChronic lymphocytic leukemia
Chronic lymphocytic leukemia
 
Pulmonary pathology of corona virus
Pulmonary pathology of corona virusPulmonary pathology of corona virus
Pulmonary pathology of corona virus
 
Pericardial fluid eosinophilia
Pericardial fluid eosinophiliaPericardial fluid eosinophilia
Pericardial fluid eosinophilia
 
Corona virus
Corona virusCorona virus
Corona virus
 
Stains
StainsStains
Stains
 
Grossing thyroid gland
Grossing thyroid glandGrossing thyroid gland
Grossing thyroid gland
 
Journal prostate and crispr
Journal prostate and crisprJournal prostate and crispr
Journal prostate and crispr
 
Eosinophilia
EosinophiliaEosinophilia
Eosinophilia
 
Journal article review
Journal article reviewJournal article review
Journal article review
 

Recently uploaded

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 

Recently uploaded (20)

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 

Bethesda Cervical CYtology

  • 1. SLIDE PRESENTATION CYTOLOGY Sansar Babu Tiwari, MBBS, PGY I Department of Pathology TUTH 1st August 2019 1
  • 2. Single Pap-stained Cervical Smear of 38 years female (Conventional cytology) Smear shows superficial, intermediate, and parabasal cells along with few endocervical cells. Atypical cells are found arranged singly, in sheets and in clusters throughout the smear. These cells are round to oval (parabasal) in shape with dense, scanty cytoplasm, enlarged hyperchromatic nuclei, coarse chromatin and irregular nuclear rim with high N : C ratio and inconspicuous nucleoli. SLIDE PRESENTATION 2
  • 3. Background shows sheets of neutrophils and coccobacilli along with hemorrhage. Necrosis and mitosis is not seen SLIDE PRESENTATION 3
  • 4. Specimen: Cervical smear Adequacy: Satisfactory for evaluation; endocervical component present General Categorization*: Epithelial cell abnormality, squamous Interpretation: High-grade squamous intra-epithelial lesion (HSIL) Adjunctive Testing*: Not done in smear Note*: Suggest colposcopic examination * Optional to mention in Report. SLIDE PRESENTATION 4
  • 11. Columnar lining changes into squamous in TZ TZ is a dynamic point, keep on changing. Move out towards ectocervix during puberty, pregnancy and pills. Move inwards when hormonal influences are absent like after menopause. CERVIX 11
  • 12. BURDEN OF CERVICAL CANCER WHO: Cervical cancer is the second most common cancer in women living in less developed regions with an estimated 570 000 new cases in 2018 (84% of the new cases worldwide). In 2018, approximately 311 000 women died from cervical cancer; more than 85% of these deaths occurring in low- and middle- income countries. High risk HPV: 16, 18, 31, 33, 35,39, 45, 51, 52, 56, 58, 59, 68, 69, 82 Low risk HPV: 6, 11, 40, 42, 43, 44, 54, 61, 72, 81 On average, 50% of HPV infections are cleared within 8 months and 90% are cleared within 2 years. CERVICAL CANCER OVERALL BURDEN 12
  • 14. HPV and cervical cancer 14 • Although HPV has been firmly established as a common cause of cervical cancer, it is not sufficient to cause cancer. • Host immune and co- carcinogen exposure influences the fate of HPV and progression to cancer.
  • 16. Incidence of cervical cytology 16
  • 17. United States Preventive Service Task Force (USPSTF), 2018 recommends: • Age to initiate: 21 years • Age to discontinue: 65 years • Between 21-29 years: Pap test every 3 years • After 30 years: One of these methods: • Pap test every 3 years • hrHPV testing alone every 5 years • Co-testing (Pap test and HPV testing) every 5 years Routine Screening of patients 17
  • 23. TYPES OF SQUAMOUS CELLS 23
  • 30. 30
  • 31. 31
  • 35. LSIL cervical cytologic specimens that contain a few cells that are suspicious for but not diagnostic of HSIL are reported as atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion(ASC-H). There was previously no recommendation regarding how to report these. Benign-appearing endometrial cells are reported only in women ≥45 years. This is a change from Bethesda 2001, which used an age threshold of ≥40 years. Pages: 191  324 Images: 186  370 Bethesda 2014 vs 2001 35
  • 36. 1. Description of specimen type and test requested – cervical or vaginal sample, conventional Pap smear, liquid-based cytology, and/or reflex human papillomavirus (HPV) test. 2. A description of specimen adequacy 3. A general categorization (optional) – Negative, epithelial cell abnormality, or other 4. An interpretation/result – Either the specimen is NILM (although organisms and reactive changes may be present) or there is an epithelial cell abnormality as defined, or there is another finding(increased risk like endometrial cells in women ≥45 years). Bethesda 2014 Overview of Report 36
  • 37. 5. A description of any ancillary testing or automated review that was performed (eg. HPV, AutoPap) 6. Educational notes and suggestions by the pathologist (optional) Bethesda 2014 Overview of Report 37
  • 38. 38
  • 39. 39
  • 40. 1. Cellularity >5000 (LBP), 8000-12000 (CP) >2000: Low cellularity but satisfactory: Post-radiation, Post-TH vaginal) 2. Endocervical component EC/TZ is not necessary for adequate specimen, only squamous cellularity is needed Adequate TZ requires at least 10 well preserved EC or squamous metaplastic cells No relation with further diagnosis with SIL 3. Obscuring factors (Blood, lubricants) >75% of sq cells (not the slide area) : unsatisfactory 4. HPV testing on unsatisfactory specimen HPV test could be falsely negative in unsatisfactory specimen However, if HPV is positive in these specimen, follow up is still needed ADEQUACY 40
  • 41. ASC refers to cytologic changes suggestive of SIL, which are qualitatively and quantitatively insufficient for definite interpretation Three essential features 1. Squamous differentiation 2. Increased ratio of nuclear to cytoplasmic area 3. Minimal nuclear hyperchromasia, chromatin clumping, irregularity, smudging or multinucleation ATYPICAL SQUAMOUS CELL 41
  • 42. • Definition: cytological changes suggestive of LSIL that are quantitatively and qualitatively insufficient for a definitive diagnosis • CRITERIA – Cells resemble superficial and intermediate squamous cells in size and configuration – Nuclei are approximately 2 and half to three times the area of the nucleus of a normal intermediate squamous cell or twice the size of a squamous metaplastic cell nucleus. – Slighlty increased N:C ratio – Minimal nuclear hyperchromasia and irregularity of chromatin distribution or nuclear shape – Nuclear abnormalities associated with dense orangeophilic cytoplasm (atypical parakeratosis) ATYPICAL SQUAMOUS CELL -UNDETERMINED SIGNIFICANCE (ASC-US) 42
  • 43. ATYPICAL SQUAMOUS CELL -UNDETERMINED SIGNIFICANCE (ASC-US) 43
  • 44. ATYPICAL SQUAMOUS CELL -UNDETERMINED SIGNIFICANCE (ASC-US) 44
  • 45. ATYPICAL SQUAMOUS CELL -UNDETERMINED SIGNIFICANCE (ASC-US) 45
  • 46. • Definition: cytological changes suggestive of HSIL that are quantitatively and qualitatively insufficient for a definitive diagnosis • Patterns: A. Small cells with high N:C Ratios (Atypical immature Metaplasia) • Cells usually occur singly or in small fragments of less than 10 cells, occasionally in conventional smears, cells may stream in mucus. • Cells are size of metaplastic cells with nuclei that are about 1.5 to 2.5 times larger than normal • N/C ratio may approximate that of HSIL ASC-H Vs HSIL: Nuclear abnormalities such as hyperchromasia, chromatin irregularity and abnormal nuclear shapes with focal irregularity favor an interpretation of HSIL. ATYPICAL SQUAMOUS CELL –CANNOT EXCLUDE HSIL (ASC-H) 46
  • 47. B. Crowded Sheet Pattern: • Dense cytoplasm, polygonal cell shape and fragments with sharp linear edges generally favor squamous over glandular (endocervical) differentiation. C. ASC-H Mimics: • Isolated endocervical cells • Degenerated endometrial cells • Macrophages • IUD: may shed rare cells with high N:C ratio • Pregnancy and post-partum: atypical appearing decidualized stromal cells ATYPICAL SQUAMOUS CELL –CANNOT EXCLUDE HSIL (ASC-H) 47
  • 48. ATYPICAL SQUAMOUS CELL –CANNOT EXCLUDE HSIL (ASC-H) 48
  • 49. • CRITERIA – Cells occur singly, in clusters, and in sheets – Cytological changes are usually confined to squamous cells with ‘mature’ intermediate or superficial squamous cell- type cytoplasm – Overall cell size is large, with fairly abundant ‘mature’ well-defined cytoplasm – Nuclear enlargement more than 3 times the area of normal intermediate nuclei results in a low but slightly increased N:C ratio Low-grade Squamous Intraepithelial Lesion (LSIL) 49
  • 50. • CRITERIA – Nuclei are generally hyperchromatic but may be normochromatic – Nuclei show variable size (anisonucleosis) – Chromatin is uniformly distributed and ranges from coarsely granular to smudgy or densely opaque – Contour of nuclear membranes is variable ranging from smooth to very irregular with notches – Binucleation and multinucleation are common – Nucleoli are generally absent or inconspicuous if present Low-grade Squamous Intraepithelial Lesion (LSIL) 50
  • 51. • CRITERIA – Koilocytosis or perinuclear cavitation consisting of a broad, sharply delineated clear peri-nuclear zone and a peripheral rim of densely stained cytoplasm is a characteristic viral cytopathic feature but is not required for the interpretation of LSIL – Cells may show increased keratinization with dense, eosinophilic cytoplasm with little or no evidence of koilocytosis – Cells with koilocytosis or dense orangeophilia must also show nuclear abnoramalities to be diagnostic of LSIL, perinuclear halos in the absence of nuclear abnormalities does not qualify for the interpretation of LSIL Low-grade Squamous Intraepithelial Lesion (LSIL) 51
  • 53. • Pseudokoilocytosis • Herpes Cytopathic Effects • Radiation Changes MIMICS OF LSIL 53
  • 58. • CRITERIA – Cells occur singly, in sheets, or in syncytial aggregates – Smaller and show less cytoplasmic maturity than cells of LSIL – Syncytial aggregates of dysplastic cells may result in hyperchromatic crowded groups – Overall cell size is variable, in general, the cells of HSIL are smaller than those of LSIL. Higher-grade lesions often contain quite small basal-type cells – Degree of nuclear enlargement is more variable than that seen in LSIL. Even if nucleus size is same as that of LSIL, cytoplasmic area is decreased leading to marked increase in N:C ratio. High-grade Squamous Intraepithelial Lesion (HSIL) 58
  • 59. • CRITERIA – Nuclei are generally hyperchromatic but may be normochromatic or even hypochromatic – Chromatin may be fine or coarsely granular and is evenly distributed – Contour of the nuclear membrane is quite irregular and frequently demonstrates prominent indentations or grooves – Nucleoli are generally absent, but may occasionally be seen, particularly when HSIL extends into endocervical gland spaces or in the background of reactive or reparative changes – Cytoplasm: variable; immature, lacy or delicate or densely metaplastic ; mature and densely keratinized as in keratinizing HSIL. High-grade Squamous Intraepithelial Lesion (HSIL) 59
  • 61. • Syncytial Aggregates/ Hyperchromatic Crowded Groups: • SIL with Endocervical Gland Involvement • Endometrial cells or Squamous Repair • Keratinizing High Grade Lesion • HSIL in Atrophy • LSIL with some features suggestive of concurrent HSIL Problematic Pattern in HSIL 61
  • 62. Note the flattening of cells at the edge of cluster. SIL with EC gland involvement 62
  • 63. • Isolated cells Reserve cells Parabasal cells Immature sq. met. cells • Histiocytes or Lymphocytes Kidney shaped Nuclear membrane notching and irregularity is absent • Decidualized Stromal cells History of pregnancy, more granular but less dense cytoplasm, prominent nucleoli. Mimics of HSIL 63
  • 67. • Definition: –WHO, 2014: SCC is an invasive epithelial tumor composed of squamous cells of varying degrees of differentiation Keratinizing vs Non-keratinizing SCC The Bethesda system doesnot subdivide squamous cell carcinoma per se. Squamous Cell Carcinoma 67
  • 68. • CRITERIA: – Presents predominantly as isolated, single cells and less commonly in cellular aggregates – Marked variation in cellular size and shape is typical, with caudate and spindle cells that frequently contain dense orangeophilic cytoplasm – Nuclei vary markedly in area, nuclear membranes may be irregular, and numerous dense opaque nuclei are often present – Chromatin pattern, when discernible, is coarsely granular and irregularly distributed with chromatin clearing Squamous Cell Carcinoma KERATINIZING 68
  • 69. • CRITERIA: – Macronucleoli may be seen but are less common in NKSCC – As keratotic changes (hyper or para) may be present but are not sufficient for the interpretation of carcinoma in the absence of nuclear abnormalities – A tumor diasthesis may be present but is usually less than that seen in NKSCC Squamous Cell Carcinoma KERATINIZING 69
  • 70. Squamous Cell Carcinoma KERATINIZING 70
  • 71. • CRITERIA: – Cells occur singly or in syncytial aggregates with poorly defined cell borders – Cells may be somewhat smaller than those of many HSIL, but display most of the features of HSIL – Nuclei demonstrate markedly irregular distribution of coarsely clumped chromatin with chromatin clearing – Nucleoli may be prominent – A tumor diasthesis consisting of necrotic debris and broken-down elements is often present Squamous Cell Carcinoma NON-KERATINIZING 71
  • 72. Squamous Cell Carcinoma NON-KERATINIZING 72
  • 73. 1. The Bethesda System of Reporting Cervical Cytopathology, 3rd edition, 2014 2. The Bethesda System and Beyond, BD Surepath 3. Robbins and Cotran Pathological Basis of Disease, 9th edition, 2015 4. Uptodate, 2019 5. www.ncbi.nlm.nih.gov/pubmed REFERENCES: 73
  • 74. 74